Patents Assigned to NORTH CELL PHARMACEUTICALS, INC.
  • Patent number: 11464761
    Abstract: A method of reducing anxiety in a non-human mammal by increasing brain serotonin levels, includes: down regulating in vivo levels of indigenous inflammatory cytokines in the nasal cavity of said non-human mammal by delivering an effective amount of an anti-inflammatory formula to said nasal cavity, which formula includes: at least one lipid-soluble antioxidant (which also functions as an anti-inflammatory agent) (the lipid-soluble antioxidant may be selected from the group consisting of alpha lipoic acid, aloe vera, omega 3 oil, N-acetylcysteine, cannabidiol, civet, oxytocin and combinations thereof); melatonin; tryptophan; and at least one essential oil. The most preferred antioxidant is N-acetylcysteine and the preferred essential oil is combination of chamomile, lavender and lemon oil.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: October 11, 2022
    Assignee: NORTH CELL PHARMACEUTICALS INC
    Inventor: Alain Martin
  • Patent number: 11458114
    Abstract: A method for, and medicinal composition for, treatment of mammalian cells for enhancing synthesis, secretion and transport of collagen to increase wound strength, that includes magnesium pyruvate; calcium pyruvate; L proline; citrulline: and a liquid carrier.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: October 4, 2022
    Assignee: NORTH CELL PHARMACEUTICALS, INC.
    Inventor: Alain Martin